Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Still lots of time
View:
Post by frebeach1 on Aug 09, 2022 2:20pm

Still lots of time

for shorters to push sp down to close the gap at .285 or lower? Dave at BOoaks.
Comment by langosta on Aug 10, 2022 5:22pm
OK! I'm gettin fed up now, the shorters are startin to annoy me. I'll give this stock another fifteen years, no more, then I'll think seriously about selling. :-)
Comment by fredgoodwinson on Aug 11, 2022 2:05am
House 9 usually riings the bell on this stock and after taking a back seat during the recent walkdown they dumped that last parcel at the close of play. We will see.
Comment by Legit62 on Aug 11, 2022 8:06am
Ya whats the deal with that Fred
Comment by fredgoodwinson on Aug 11, 2022 8:13am
Who`s to say - if anything at all - but having come this far it`s win or bust for me!
Comment by Legit62 on Aug 11, 2022 8:19am
Im thinking by end of this month we should have a clearer picture and hopefully by end of year we will be very very happy and can meet in Vegas, i owe Skyes1 a round of golf by the way. He must be on vacation lately
Comment by fredgoodwinson on Aug 11, 2022 8:25am
A clearer picture on NMIBC by the end of the month and a clearer picture on the anti-viral vaccine not long after. Exciting times and whatever the outcomes it will be good to get an idea of where we are having been in the dark for so long.
Comment by Legit62 on Aug 11, 2022 8:37am
Agree, i keep forgetting about the anti-viral vaccine news, that should be huge
Comment by O12009 on Aug 11, 2022 9:02am
  I think that's BMO Nesbitt Burns
Comment by fredgoodwinson on Aug 11, 2022 9:22am
That is correct 012009. Merely a personal observation of historic short term trading cycles that is no guide to the future.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250